The association between variability of risk factors and complications in type 2 diabetes mellitus: a retrospective study

Author:

Chen Mengjie,Pu Lihui,Gan Yuqin,Wang Xiaoxia,Kong Laixi,Guo Maoting,Yang Huiqi,Li Zhe,Xiong Zhenzhen

Abstract

AbstractThe variability in diabetes risk factors, such as uric acid and lipids, may influence the development of complications. This study aimed to investigate the influence of such variability on the occurrence of diabetic complications. A retrospective analysis of electronic medical records was conducted with type 2 diabetic patients who received treatment at a tertiary care hospital in Chengdu, Sichuan Province, between 2013 and 2022. The risk factor variability is presented as the standard deviation (SD). The associations between the variability and complications were examined using a binary logistic regression model. The study included 369 patients with type 2 diabetes. The findings revealed that outpatient special disease management served as a protective factor against the development of complications [OR = 0.53, 95% confidence interval (CI) (0.29–0.10)], particularly for the prevention of diabetic peripheral neuropathy [OR = 0.51, 95% CI (0.30–0.86)]. Variability in total cholesterol (TC-SD) was found to be a risk factor for the development of complications [OR = 2.42, 95% CI (1.18–4.97)] and acted as a risk factor for diabetic peripheral vasculopathy [OR = 2.50, 95% CI (1.25–5.02)]. TC-SD is a risk factor for the occurrence of diabetic peripheral neuropathy and diabetic peripheral vasculopathy, whereas outpatient special disease management functions as a protective factor against complications and diabetic peripheral neuropathy. Thus, in addition to glycaemic control, the regulation of lipid levels should be emphasized, particularly among patients without outpatient special disease management, to delay the onset of complications.

Funder

the 2022 Clinical Medicine Research Center for Geriatric Diseases Open Topics

Publisher

Springer Science and Business Media LLC

Reference67 articles.

1. Bo, Z. & Wenying, Y. Outlook for the epidemiology and prevention of diabetes in China. Chin. J. Diab. 11(1), 7–10 (2019).

2. Chinese, M. A. D. B. Guideline for the prevention and treatment of type 2 diabetes mellitus in China (2020 edition) (Part1). Chin. J. Pract. Internal Med. 41(08), 668–695 (2021).

3. Fowler, M. J. Microvascular and macrovascular complications of diabetes. Clin. Diab. 26(2), 77–82 (2011).

4. Zhuo, X., Zhang, P. & Hoerger, T. J. Lifetime direct medical costs of treating type 2 diabetes and diabetic complications. Am. J. Prev. Med. 45(3), 253–261 (2013).

5. Goldhaber-Fiebert, J. D. et al. Inpatient treatment of diabetic patients in Asia: Evidence from India, China Thailand and Malaysia. Diabet. Med. 27(1), 101–108 (2010).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3